Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "piggyBac transposable element derived 4 pseudogene" (ENSG00000273719) is a human genomic locus that derives from the domestication of a piggyBac superfamily transposable element. PiggyBac is a class II DNA transposon first isolated in insects, distinguishing itself through its precise excision and TTAA target site specificity[3][5]. In mammals, several piggyBac-derived genes—such as PGBD3—have evolved through fusion or domestication; some retain zinc-finger or DNA-binding domains[4]. However, pseudogenes like "piggyBac transposable element derived 4 pseudogene" have lost protein-coding potential and do not exhibit regulatory, enzymatic, or signaling activity. They represent transposon-derived genomic "fossils" and do not play roles as functional molecules or disease-associated genes.
Not applicable—no drug mechanisms reported or relevant for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on piggyBac transposable element derived 4 pseudogene.